Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | ROIV | ASND | ||
| Company | Intra-Cellular Ther | Roivant Sciences Ltd | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.75 | 11.02 | 135.67 | ||
| High | 76.13 | 11.12 | 136.39 | ||
| Low | 74.62 | 10.94 | 134.55 | ||
| Last | 75.11 | 11.03 | 135.22 | ||
| Change | +0.25 | +0.03 | +0.01 | ||
| % Change | +0.33% | +0.27% | +0.01% | ||
| Volume | 119,238 | 542,716 | 53,145 | ||
| 20-Day Average Volume | 1,569,921 | 5,249,729 | 287,090 | ||
| Previous Close | 74.86 | 11.00 | 135.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 73.59 | 10.95 | 135.87 | ||
| 20-Day Raw Stochastic | 65.86% | 55.04% | 57.07% | ||
| 20-Day Relative Strength | 56.38% | 52.47% | 50.76% | ||
| Weighted Alpha | +27.46 | -0.33 | +38.30 | ||
| Today's Opinion | 100% Buy | 100% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 96% Buy | 8% Buy | ||
| Last Month's Opinion | 72% Buy | 24% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.40% since 07/15/24 | -3.52% since 07/15/24 | -1.19% since 07/15/24 | ||
| Low | 74.45 on 07/18/24 | 10.92 on 07/19/24 | 132.59 on 07/19/24 | ||
| High | 79.88 on 07/16/24 | 11.72 on 07/16/24 | 142.21 on 07/16/24 | ||
| 1-Month | |||||
| %Chg | -1.76% since 06/21/24 | +3.79% since 06/21/24 | +5.91% since 06/21/24 | ||
| Low | 66.26 on 07/01/24 | 10.33 on 07/05/24 | 126.37 on 06/24/24 | ||
| High | 79.88 on 07/16/24 | 11.72 on 07/16/24 | 142.21 on 07/16/24 | ||
| 3-Month | |||||
| %Chg | +0.93% since 04/22/24 | +4.67% since 04/22/24 | -4.71% since 04/22/24 | ||
| Low | 64.09 on 05/20/24 | 10.19 on 05/31/24 | 116.63 on 05/14/24 | ||
| High | 79.88 on 07/16/24 | 11.72 on 07/16/24 | 147.45 on 04/23/24 | ||
| 6-Month | |||||
| %Chg | +11.75% since 01/22/24 | +7.20% since 01/22/24 | +0.93% since 01/22/24 | ||
| Low | 62.78 on 02/22/24 | 9.69 on 02/05/24 | 116.63 on 05/14/24 | ||
| High | 84.89 on 04/16/24 | 12.00 on 03/04/24 | 161.00 on 02/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,903,344 | 8,125,942 | 7,873,413 | ||
| Shares Outstanding, K | 105,575 | 738,722 | 58,231 | ||
| Annual Sales | 464,370,000 | 124,800,000 | 288,670,000 | ||
| Annual Net Income | -139,670,000 | 4,348,930,000 | -521,070,000 | ||
| Last Quarter Sales | 144,870,000 | 28,930,000 | 104,110,000 | ||
| Last Quarter Net Income | -15,250,000 | -151,120,000 | -142,260,000 | ||
| 60-Month Beta | 1.01 | 1.24 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 05/07/24 | -0.23 on 05/30/24 | -2.48 on 05/02/24 | ||
| Latest Earnings Date | 08/01/24 | 08/12/24 | 09/03/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||